| Concluding Remarks for Special Issue HTLV-HIV Co-Infections A Vallejo, M Abad-Fernández Viruses 15 (4), 963, 2023 | | 2023 |
| OMIP‐087: Thirty‐two parameter mass cytometry panel to assess human CD4 and CD8 T cell activation, memory subsets, and helper subsets A Sponaugle, M Abad‐Fernandez, N Goonetilleke Cytometry Part A 103 (3), 184-188, 2023 | 4 | 2023 |
| Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication (vol 12, 666991, 2021) Y Xu, AM Weideman, M Abad-Fernandez, KRR Mollan, S Kallon, S Samir, ... FRONTIERS IN IMMUNOLOGY 13, 2023 | | 2023 |
| Corrigendum: Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication Y Xu, AM Weideman, M Abad-Fernandez, KR Mollan, S Kallon, S Samir, ... Frontiers in Immunology 13, 1104661, 2023 | | 2023 |
| HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1 M Abad-Fernández, FJ Hernández-Walias, MJ Ruiz de León, ... Viruses 14 (11), 2472, 2022 | 2 | 2022 |
| CD8 T Cell Virus Inhibition Assay Protocol Y Xu, AM Weideman, M Abad-Fernandez, KR Mollan, S Kallon, S Samir, ... Bio-protocol 12 (6), e4354-e4354, 2022 | | 2022 |
| Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication Y Xu, AM Weideman, M Abad-Fernandez, KR Mollan, S Kallon, S Samir, ... Frontiers in immunology 12, 666991, 2021 | 3 | 2021 |
| Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated with HIV-1 Rebound after Four Weeks of Interruption of Antiretroviral Therapy A Vallejo, S Molina-Pinelo, B De Felipe, M Abad-Fernández, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 85 (2), 252-256, 2020 | 4 | 2020 |
| Correction for Garrido et al., “Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo” C Garrido, M Abad-Fernandez, M Tuyishime, JJ Pollara, G Ferrari, ... Journal of Virology 94 (11), 10.1128/jvi. 00223-20, 2020 | | 2020 |
| HIV-specific T cell responses are highly stable on antiretroviral therapy Y Xu, IM Trumble, JA Warren, G Clutton, M Abad-Fernandez, J Kirchnerr, ... Molecular Therapy Methods & Clinical Development 15, 9-17, 2019 | 25 | 2019 |
| Precision mouse models with expanded tropism for human pathogens A Wahl, C De, M Abad Fernandez, EM Lenarcic, Y Xu, AS Cockrell, ... Nature biotechnology 37 (10), 1163-1173, 2019 | 90 | 2019 |
| Human cytomegalovirus-vectored vaccines against HIV M Abad-Fernandez, N Goonetilleke Current Opinion in HIV and AIDS 14 (2), 137-142, 2019 | 19 | 2019 |
| Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo C Garrido, M Abad-Fernandez, M Tuyishime, JJ Pollara, G Ferrari, ... Journal of virology 92 (12), 10.1128/jvi. 00235-18, 2018 | 120 | 2018 |
| Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1–HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or … M Abad-Fernández, F Dronda, A Moreno, JL Casado, MJ Pérez-Elías, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 286-290, 2015 | 4 | 2015 |
| Visceral leishmaniasis as an independent cause of high immune activation, T‐cell senescence, and lack of immune recovery in virologically suppressed HIV‐1‐coinfected patients JL Casado, M Abad‐Fernández, S Moreno, MJ Pérez‐Elías, A Moreno, ... HIV medicine 16 (4), 240-248, 2015 | 34 | 2015 |
| Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy M Abad-Fernández, A Moreno, F Dronda, S del Campo, C Quereda, ... AIDS 29 (4), 401-409, 2015 | 7 | 2015 |
| High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis A Vallejo, M Abad-Fernandez, S Moreno, A Moreno, MJ Perez-Elias, ... European journal of clinical microbiology & infectious diseases 34, 267-275, 2015 | 15 | 2015 |
| Expression of gut‐homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV‐1‐infected patients? M Abad‐Fernández, C Gutiérrez, N Madrid, B Hernández‐Novoa, L Díaz, ... HIV medicine 16 (1), 15-23, 2015 | 3 | 2015 |
| Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir M Abad-Fernández, C Cabrera, E García, A Vallejo Journal of Clinical Virology 59 (3), 204-207, 2014 | 2 | 2014 |
| CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption A González-Serna, M Abad-Fernández, N Soriano-Sarabia, M Leal, ... Journal of Clinical Virology 58 (4), 703-709, 2013 | 8 | 2013 |
